Guideline conformity treatment in young women with early-onset breast cancer in Germany

Telja Pursche, Marianne Hedderich, Alessa Heinrichs, Kristin Baumann, Constanze Banz-Jansen, Achim Rody, Annika Waldmann, Dorothea Fischer

2 Citations (Scopus)


Background: The purpose of the study was to characterize the treatment of young mothers with breast cancer in Germany and to investigate whether it followed applicable guidelines. Method: Retrospective data obtained between 2002 and 2011 for 1,053 mothers with children of < 12 years of age with adjuvantly treated loco-regional primary breast cancer were analyzed. Collected data included sociodemographic data, TNM stage, biology of tumor and therapies. Actually received therapies were compared to those suggested in guideline treatment plans. Results: The mean age of the patients was 39 years. 97% of the women with node positivity received an axillary dissection. Overall, 90% of the patients received chemotherapy with a guideline adherence range of 87-99% depending on clinical parameters. For radiation therapy, guideline adherence was high (range 82-100%). 95% of the patients with a hormone receptorpositive tumor received endocrine therapy; in 94%, tamoxifen therapy was performed in compliance with guidelines, whereas gonadotropin-releasing hormone (GnRH) agonist therapy complied with the guidelines in 52% of the cases. Conclusion: Guideline adherence in young mothers with breast cancer in Germany was high (with the exception of GnRH therapy), as comorbidity or the ambiguity of the therapeutic success does not need to be considered as much in this young, otherwise usually healthy, cohort compared to an age-heterogeneous group.

Original languageEnglish
JournalBreast Care
Issue number5
Pages (from-to)349-354
Number of pages6
Publication statusPublished - 01.01.2014


Dive into the research topics of 'Guideline conformity treatment in young women with early-onset breast cancer in Germany'. Together they form a unique fingerprint.

Cite this